Associated Papers
Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
Saldarriaga J et al.
Histopathology, 2017
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma.
Poussin K et al.
Oncoimmunology, 2013
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Rebouissou S et al.
Nature, 2009
Select a paper to view details